An error occurred retrieving publication content to display, please try again.
Page not found (404)
Sorry - the page you requested could not be found.
Please choose a page from the navigation or try a website search above to find the information you need.
Toolkit
In this smaller than planned observational study, ex-vivo lung perfusion was associated with lower survival, more side effects and higher costs, but also with increased donor lung availability.
1 Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
2 Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
3 Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK
4 Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK
5 Service user and lay member of study research team, ,
6 Papworth Hospital NHS Foundation Trust, Cambridge, UK
7 University Hospital of South Manchester NHS Foundation Trust, Manchester, UK
8 Royal Brompton and Harefield Hospital NHS Foundation Trust, London, UK
9 Queen Elizabeth Hospital NHS Foundation Trust, Birmingham, UK
* Corresponding author Email: a.j.fisher@newcastle.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
Report Content
The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
Responses to this report
No responses have been published.
An error has occurred in processing the XML document